來源紀錄
Quantitative assist for immunohistochemistry scoring
廠商報告廠商
此語言的正文尚未翻譯，暫以英文顯示。
The source is PathAI’s company website, dated in this index as 1 February 2025, read as a vendor description of algorithms that estimate immunohistochemistry staining. Ibex is named as another vendor in the same class. The page is not an independent concordance study. No percentage agreement is copied, because those figures are assay-specific and easy to over-read.
- 來源日期
- 2025年2月1日 · 年份 2025
- 證據標籤
- 廠商報告
- 來源類型
- 廠商
完整引用
PathAI
PathAI. Company website, dated in this index as 1 February 2025. https://www.pathai.com/ Vendor description of pathology algorithms. Ibex is named only as another company offering quantitative immunohistochemistry assist. Not an independent assay study.
已公開的關鍵事實
- The cited page is a vendor website, not a peer-reviewed concordance study.
- The workflow is an estimate of staining extent, such as Ki-67 or PD-L1, on a digitized slide that already has a clinical scoring scheme.
- A pathologist checks the region and the number before the score enters the report.
- The signed score remains a pathology result.
- No concordance figure is copied. Vendor white papers stay vendor-reported until an independent study matches the assay in local use.
供教育和市場掃描的目錄條目。不是醫療建議，也不是背書。